A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis
Clinical trial NCT03928704 · COMPLETED
Trial details
- NCT number
- NCT03928704
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-25
- Primary completion
- 2022-06-29
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.